Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)
Avatar

Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, and How to Salvage Therapy

By Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018) FEATURING Sundar Jagannath
October 2018
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
Indy Hematology Review

17th Indy Hematology Review

Fri, Aug 14, 2020
10:37
Moffitt Cancer Center's 16th Annual Clinical Breakthroughs & Challenges in Hematologic Malignancies

State of the Art in the Management of Multiple Myeloma: Smoldering MM, I...

Feat. K. Shain
25:51
KU ASH 2018 Review: Current Updates in Hematologic Diseases

MM - Overview of Trials Presented at ASH 2018

Feat. A. Abdallah
12:03
Andrew Cowan

BCMA CAR-T + Gamma Secretase Inhibitor Appear to Be Well Tolerated in R/...

08:15
2018 Pan Pacific Lymphoma Conference

Evolution of Myeloma Induction Regimens

Feat. S. Holstein
17:03
Ajai Chari

Diagnosing Smoldering Multiple Myeloma

19:49
Gareth J Morgan

Contemporary Design of MM Treatment: Developing New Therapeutic Endpoint...

12:16
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Discrepancy Between Real World vs. Clinical Trial Data in Relapsed/Refra...

Feat. M. Dimopoulos
09:50
Nina Shah

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...

19:41
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...

06:12
Indy Hematology Review

Targeting Mutations in Myeloma with Venetoclax and Development of the Fi...

Feat. K. Anderson
05:05
Indy Hematology Review

Risk of Progression of Smoldering Myeloma to Active Multiple Myeloma

Feat. K. Anderson
14:15
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

MRD in Multiple Myeloma Isn't Ready for Prime Time: More Patients Can Ac...

Feat. T. Martin
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

15:11
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myeloma

13:27
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

17:03
Thomas Martin

Novel Clinical Trials for Smoldering Multiple Myeloma in 2018

17:17
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

Emerging Data on Management and Imaging of Myeloma Bone Disease

Feat. M. Dimopoulos
16:22
Society of Hematologic Oncology Sixth Annual Meeting (SOHO 2018)

FDA Approves Selinexor for Refractory Multiple Myeloma, STORM Study

Feat. S. Jagannath
21:41
Natalie Callander

Smoldering Myeloma: Risk Stratification and Therapeutic Options

12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson